Assessing Mental Illness Recovery
MARS
Assessing Recovery in Veterans With Serious Mental Illness
1 other identifier
observational
250
1 country
3
Brief Summary
In 2003 the VA Undersecretary's Action Agenda mandated that mental health services throughout the system be transformed to a recovery model. That mandate and many of the Workgroup recommendations have since been formalized in the Uniform Mental Health Services Package, which specifies a range of recovery-oriented services that must be available to veterans. A key aspect of these policy mandates is the need to assess recovery status of veterans and to monitor their progress over time as a way to evaluate the effectiveness of recovery services. However, there is no established instrument that is suitable for system-wide application. The purpose of this project is to develop a reliable, valid and practical measure of recovery, and use the measure in a study to better understand recovery in individuals with serious mental illness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 5, 2010
CompletedFirst Posted
Study publicly available on registry
January 7, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedResults Posted
Study results publicly available
January 10, 2017
CompletedMarch 8, 2017
January 1, 2017
3.5 years
January 5, 2010
November 10, 2016
January 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive and Negative Symptom Scale (PANSS)
The PANSS is a clinician-rated measure of the presence and severity of symptoms of psychosis. A total score was calculated by averaging the responses on the items (range=1 to 7) scores, with higher scores indicating greater severity of psychiatric symptoms.
~1-year
Secondary Outcomes (1)
Maryland Assessment of Recovery in Serious Mental Illness
~ 1-year
Study Arms (1)
Maryland Assessment of Recovery in Serious Mental Illness
Individuals with serious mental illness treated in mental health outpatient programs
Eligibility Criteria
We have elected to focus on individuals meeting accepted criteria for serious mental illness, including a diagnosis of schizophrenia or schizoaffective disorder, bipolar I disorder (with mania), and major depression with psychosis. Individuals meeting these criteria represent a large population with significant costs and health concerns for VA. Further, they are the primary target of efforts to transform mental health care in VA to a recovery model, making this an arena in particular need of a sound recovery instrument. We have elected to limit our sample to people in treatment for several reasons. One can surmise that most people not in treatment are new cases, very ill (e.g., homeless), or doing very well.
You may qualify if:
- chart diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder I (with mania), or major depression with psychotic features, with a history of a minimum of 2 psychotic exacerbations, or Psychosis NOS
- A minimum of 2 psychotic exacerbations(confirmed by medical record, provider report, or patient self-report);
- Are receiving services from participating study sites and have had a minimum of two service visits within the last 6 months;
- Have received mental health services for a minimum of 3-years;
- Age between 25 and 65;
- Able to provide informed consent; and
- Able to complete protocol assessments (estimation from medical record and/or mental health provider that person can read at 5th grade level and sustain attention to study tasks for required period of time).
You may not qualify if:
- Severe or profound mental retardation as indicated by chart review
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Washington DC VA Medical Center
Washington D.C., District of Columbia, 20420, United States
University of Maryland, Division of Psychiatry
Baltimore, Maryland, 21201, United States
VA Maryland Health Care System, Baltimore
Baltimore, Maryland, 21201, United States
Biospecimen
no specimens collected
Results Point of Contact
- Title
- Dr. Amy Drapalski
- Organization
- VISN 5 MIRECC
Study Officials
- PRINCIPAL INVESTIGATOR
Alan S. Bellack, PhD
VA Maryland Health Care System, Baltimore
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 5, 2010
First Posted
January 7, 2010
Study Start
January 1, 2010
Primary Completion
July 1, 2013
Study Completion
September 1, 2013
Last Updated
March 8, 2017
Results First Posted
January 10, 2017
Record last verified: 2017-01